Academy of Finland  
 
 
 
 
 
Funding decision
 
Applicant / Contact person Sundvall, Maria Helena
Organisation University of Turku
Project title Novel mechanistic insights of BRCA2 at molecular level with therapeutic implications in prostate cancer
Decision No. 316130
Decision date 30.05.2018
Funding period 01.09.2018 - 31.08.2022
Funding 296 124
   
Project description
Prostate cancer is the most common cancer in men. The standard treatment of metastatic prostate cancer is androgen deprivation therapy. However, the majority of patients develop a castration resistance disease and respond to current therapies only for a short period of time. Better understanding of the disease at molecular level is needed to improve and develop more personalized treatments. Recent data indicates that approximately 20% of patients with castration resistant prostate cancer have mutations in DNA repair genes, such as BRCA2. The purpose of this study is to investigate the functional significance of BRCA2 in prostate cancer progression. By using human cancer cell cultures and mouse models as well as patient samples this study aims i) at finding novel molecular mechanisms relevant for aggressive prostate cancer and ii) at providing bases to improve current therapeutic modalities.